A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment - Related Studies

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

This study has been completed.

Study NCT00438048. Last updated on May 21, 2008. Information provided by Pontificia Universidad Catolica de Chile

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Primary Sjogren
		Secondary Sjogren
		Xerostomia

2	Additional conditions recognized in this trial
		Neoplasm Metastasis
		Sjogren's Syndrome

3	More general conditions related to this trial
		Arthritis
		Arthritis, Rheumatoid
		Autoimmune Diseases
		Connective Tissue Diseases
		Dry Eye Syndromes
		Eye Diseases
		Immune System Diseases
		Joint Diseases
		Lacrimal Apparatus Diseases
		Mouth Diseases
		Musculoskeletal Diseases
		Neoplasms
		Neoplastic Processes
		Pathologic Processes
		Rheumatic Diseases
		Salivary Gland Diseases
		Stomatognathic Diseases

4	Interventions listed in this trial
		pilocarpine
		Artificial Saliva

5	More general drug interventions related to this trial
		Autonomic Agents
		Cholinergic Agents
		Cholinergic Agonists
		Miotics
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Agonists
		Neurotransmitter Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		Pontificia Universidad Catolica de Chile
		Formulario MAgistral Farmacias Ahumada